Replies to post #1886 on Momenta Pharmaceuticals, Inc. (MNTA)

[Mpower]

TEVA won't back down and the analysts are for the most part ignorant. (You heard the RBS call earlier this week) TEVA will keep spinning this story. I really thought that a year after mL sole-generic approval, that MNTA would be, at least, in the high teens or low twenties... boy was I wrong. (unlike some on this board, i am willing to admit my mistakes... but i also intend to learn from them)

[jbog]

joethdo,

Someone should be taking notes because Teva through its shrewd PR program spun a FDA denial letter and an accelerated trial date to its advantage.

In the long run I think both events are negative for Teva.